Skip to content

    Mirum Pharmaceuticals (MIRM) stock price & financials

    View MIRM earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+30.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $90.38M
    $99.41M
    $111.58M
    $127.78M
    $133.01M
    +47.2%
    $148.93M
    +49.8%
    $159.88M
    +43.3%
    $176.24M
    +37.9%
    Strengthening
    Operating Profit
    -$12.68M
    -$24.22M
    -$15.18M
    -$4.99M
    $2.60M
    -$4.57M
    +81.1%
    -$789.47M
    -5099.7%
    -$42.54M
    -752.6%
    Weakening
    Net Profit
    -$14.23M
    -$23.79M
    -$14.68M
    -$5.86M
    $2.90M
    -$5.73M
    +75.9%
    -$790.15M
    -5283.6%
    -$67.23M
    -1047.0%
    Weakening
    EPS
    $-0.30
    $-0.30
    $-0.12
    $0.06
    $-13.43
    -4376.7%
    $-1.06
    -783.3%
    Weakening
    Other Income
    Interest
    $3.59M
    $3.58M
    $3.60M
    $3.59M
    $3.61M
    +0.6%
    $3.60M
    +0.5%
    $3.62M
    +0.6%
    $2.62M
    -27.1%
    Weakening
    Depreciation
    Profit before Tax
    -$13.89M
    -$24.37M
    -$13.65M
    -$5.46M
    $2.64M
    -$4.96M
    +79.6%
    -$789.68M
    -5686.0%
    -$65.54M
    -1100.5%
    Weakening
    MarginsOPM
    -14.0%
    -24.4%
    -13.6%
    -3.9%
    2.0%
    -3.1%
    +87.4%
    -493.8%
    -3528.1%
    -24.1%
    -519.0%
    Weakening
    Tax
    -2.5%
    2.4%
    -7.5%
    -7.4%
    -9.9%
    -296.4%
    -15.4%
    -754.7%
    -0.1%
    +99.2%
    -2.6%
    +64.9%
    Weakening
    ReturnsROIC
    0.9%
    1.6%
    1.0%
    0.4%
    -0.2%
    -120.4%
    0.4%
    -75.9%
    51.8%
    +5283.6%
    4.4%
    +1047.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$11.97M$142.09M$31.34M$28.00M$286.33M$222.50M$296.68M$330.73M
    Short-Term Investments
    Total Current Assets$119.36M$236.35M$166.59M$190.22M$387.54M$392.79M$549.68M$636.31M
    Net PP&E$3.73M$3.24M$2.55M$2.35M$1.99M$9.81M$10.60M$14.28M
    Goodwill
    Intangibles$0$18.74M$58.95M$252.93M$249.82M$260.92M$247.39M
    Total Assets$146.71M$240.86M$294.65M$352.91M$646.62M$670.75M$842.81M$1.04B
    LiabilitiesTotal Current Liabilities$13.08M$18.46M$42.60M$64.73M$87.06M$126.55M$205.80M$222.79M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$3.25M$2.63M$1.90M$1.26M$617.0K$7.97M$7.52M$10.46M
    Total Liabilities$16.36M$68.77M$174.44M$210.87M$397.95M$445.11M$528.12M$1.06B
    EquityCommon Stock & APIC$2.0K$3.0K$3.0K$4.0K$5.0K$5.0K$5.0K$6.0K
    Retained Earnings-$69.90M-$173.17M-$257.16M-$392.82M-$556.24M-$644.18M-$667.54M-$1.52B
    Total Equity$130.35M$172.09M$120.21M$142.04M$248.67M$225.64M$314.69M-$10.42M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$39.36M-$89.08M-$132.76M-$120.14M-$70.94M$10.32M$55.83M-$227.27M
    Cash from Investing-$127.78M$37.87M$48.55M$7.70M-$107.20M-$90.13M-$23.95M-$172.78M
    Cash from Financing$127.18M$181.29M$73.47M$109.09M$336.60M$17.70M$40.14M$506.61M
    SummaryCapital Expenditure-$281.0K-$225.0K-$24.0K-$278.0K-$109.0K-$993.0K-$954.0K-$1.47M
    Free Cash Flow-$39.64M-$89.30M-$132.78M-$120.41M-$71.05M$9.33M$54.87M-$228.74M
    FCF Margin-693.8%-156.3%-38.1%2.8%10.5%-37.0%

    Ratios